The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation (Q39971704)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

16 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation (English)

1 reference

16 September 2017

Bas Kreike

3

0 references

Dimitry S A Nuyten

4

object named as

Dimitry Nuyten

1 reference

16 September 2017

Joost Meijer

1

1 reference

16 September 2017

Janneke Ogink

2

1 reference

16 September 2017

Karin E de Visser

5

1 reference

16 September 2017

Ed Roos

6

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

68

1 reference

16 September 2017

issue

12

1 reference

16 September 2017

page(s)

4701-4708

1 reference

Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes

16 September 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Interaction of EGF receptor and grb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

A cytokine-mediated link between innate immunity, inflammation, and cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Cancer and the chemokine network

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Chemokines take centre stage in vascular biology

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Second-generation shRNA libraries covering the mouse and human genomes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

High-intensity p38 kinase activity is critical for p21(cip1) induction and the antiproliferative function of G(i) protein-coupled receptors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Oxidative stress is the new stress

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Chemokines and cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Distinct internalization of M2 muscarinic acetylcholine receptors confers selective and long-lasting desensitization of signaling to phospholipase C

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Retention of CXCR4 in the endoplasmic reticulum blocks dissemination of a T cell hybridoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

The membrane-bound chemokine CXCL16 expressed on follicle-associated epithelium and M cells mediates lympho-epithelial interaction in GALT

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Involvement of chemokine receptors in breast cancer metastasis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

The chemokine network in cancer--much more than directing cell movement

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Transmembrane chemokines: versatile 'special agents' in vascular inflammation.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-0482

Identifiers

DOI

10.1158/0008-5472.CAN-08-0482

1 reference

16 September 2017

1 reference